Actual market that is available to BOT is what I am unsure about. I know BOT have quoted all those figures, and indeed, sales to only a small percentage of that market would see us do well, but I am curious why Qbrexza has only sold $25m when it seems a very similar product to SB. Yes, there are differences to application and our trial results are better, but I'm not sure Qbrexza is understood by the hyperhidrosis market as a turkey. So I do wonder if BOT will have access to as much of a market as has been mentioned. But believe me - I do have my fingers crossed.
Price predictions, page-60
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $3.489M | 9.104M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 893523 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 159482 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |